News | February 07, 2022
Serum receives green light for Omicron variant vaccine
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Pfizer and Moderna are also working on vaccines that target the Omicron variant
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
The need is to vaccinate people who have not contracted Covid-19
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The vaccines are currently only authorised for emergency use in the country
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
